EURONEXT:BETR
A Better Life Pharma
- Stock
Last Close
0.10
24/09 20:00
Market Cap
14.69M
Beta: 1.42
Volume Today
7K
Avg: 160.13K
PE Ratio
−4.23
PFCF: −4.62
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jan '14 | Jan '15 | Jan '16 | Jan '17 | Jan '18 | Jan '19 | Jan '20 | Jan '21 | Jan '22 | Jan '23 | Jan '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -753.88K - | -1.00M 32.98% | -11.99M 1,096.03% | -8.23M 31.39% | -149.50K 98.18% | -9.15M 6,017.78% | -19.59M 114.17% | -36.35M 85.57% | -12.16M 66.55% | -9.37M 22.92% | -2.89M 69.18% | |
depreciation and amortization | 455 - | 455 0% | 450.08 1.08% | 69.78K 15,404.84% | 30.94K 55.67% | 900.65K 2,811.38% | 1.41M 56.32% | 342.81K 75.65% | 18.44K 94.62% | 18.43K 0.01% | ||
deferred income tax | 118.72K - | 1.32M - | 7.92M 498.03% | 11.35M 43.25% | ||||||||
stock based compensation | 349.16K - | 31.57K - | 1.60M 4,961.16% | 826.63K 48.26% | 1.23M 48.97% | 951.07K 22.77% | 500.26K 47.40% | |||||
change in working capital | 106.79K - | 144.68K 35.49% | 111.00K 23.28% | 760.79K 585.42% | 626.58K 17.64% | 727.79K 16.15% | 302.12K 58.49% | -1.54M 611.12% | -1.32M 14.75% | 3.43M 360.83% | 321.61K 90.63% | |
accounts receivables | -92.88K - | -349.90K 276.72% | 181.03K 151.74% | 310.01K 71.25% | -22.35K 107.21% | |||||||
inventory | 92.88K - | 349.90K 276.72% | -181.03K 151.74% | -310.01K 71.25% | ||||||||
accounts payables | 52.93K - | 98.84K 86.72% | 95.35K 3.53% | 572.54K 500.47% | 659.28K 15.15% | 470.78K 28.59% | 1.05M 123.10% | -993.93K 194.63% | -1.16M 16.47% | 2.21M 291.17% | -701.56K 131.70% | |
other working capital | 53.85K - | 45.84K 14.87% | 15.65K 65.87% | 188.25K 1,103.08% | -32.70K 117.37% | 257.01K 885.87% | -748.21K 391.12% | -550.26K 26.46% | -158.81K 71.14% | 1.22M 868.56% | 343.96K 71.82% | |
other non cash items | 619.36K - | 804.73K 29.93% | 11.18M 1,289.55% | 6.90M 38.28% | -996.07K 114.43% | 1.18M 218.89% | 479.13K 59.54% | 18.21M 3,701.34% | 1.02M 94.38% | 3.47M 238.86% | 117.36K 96.61% | |
net cash provided by operating activities | -27.28K - | -52.66K 93.08% | -229.15K 335.12% | -495.06K 116.04% | -488.06K 1.41% | -4.98M 919.87% | -7.88M 58.32% | -7.16M 9.08% | -11.20M 56.36% | -1.50M 86.58% | -2.47M 64.44% | |
investments in property plant and equipment | -853.29K - | -542.74K 36.39% | -96.61K 82.20% | |||||||||
acquisitions net | 2.78K - | -432.92K 15,678.37% | 25.07K 105.79% | |||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | -165.43K - | |||||||||||
net cash used for investing activites | -1.06K - | 0.00 100.00% | 0.00 50% | -850.51K 5,844,660,215,873,536,000% | -1.14M 34.17% | -71.55K 93.73% | ||||||
debt repayment | -770.53K - | -3.83M 397.53% | -499.93K 86.96% | -250K 49.99% | -300K - | |||||||
common stock issued | 335.79K - | 256.87K 23.50% | 399.73K 55.62% | 1.54M 284.26% | 16.31M 961.87% | 1.29M 92.09% | 11.44M 787.33% | 833.31K 92.72% | 2.20M 164.19% | |||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 27.84K - | 52.69K 89.22% | 0.00 100.00% | 264.76K 151,615,932,064,103,712% | 45.03K 82.99% | 5.06M 11,140.46% | -250K 104.94% | 3.30M 1,420.09% | 42.82K 98.70% | 502.58K 1,073.80% | ||
net cash used provided by financing activities | 27.84K - | 52.69K 89.22% | 335.79K 537.31% | 521.62K 55.34% | 444.76K 14.74% | 5.83M 1,210.18% | 12.23M 109.82% | 4.09M 66.55% | 11.23M 174.68% | 1.34M 88.11% | 2.50M 87.26% | |
effect of forex changes on cash | -6.62K - | 26.88K 506.33% | -15.80K 158.78% | -3.52K 77.74% | 2.22K 163.07% | 19.80K 792.92% | -11.91K 160.14% | 2.42K 120.29% | -56 102.32% | |||
net change in cash | 569 - | 23 95.96% | 98.96K 430,166.99% | 53.44K 46.00% | -59.11K 210.60% | -4.50K 92.38% | 3.21M 71,301.24% | -3.13M 197.51% | 18.79K 100.60% | -165.21K 979.18% | 29.08K 117.60% | |
cash at beginning of period | 475 - | 1.04K 119.79% | 1.17K 12.33% | 93.88K 7,905.20% | 138.70K 47.74% | 79.30K 42.82% | 74.80K 5.68% | 3.28M 4,287.30% | 154.72K 95.29% | 173.51K 12.15% | 8.31K 95.21% | |
cash at end of period | 1.04K - | 1.07K 2.20% | 100.13K 9,284.64% | 147.32K 47.12% | 79.59K 45.98% | 74.80K 6.02% | 3.28M 4,287.30% | 154.72K 95.29% | 173.51K 12.15% | 8.31K 95.21% | 37.38K 350.03% | |
operating cash flow | -27.28K - | -52.66K 93.08% | -229.15K 335.12% | -495.06K 116.04% | -488.06K 1.41% | -4.98M 919.87% | -7.88M 58.32% | -7.16M 9.08% | -11.20M 56.36% | -1.50M 86.58% | -2.47M 64.44% | |
capital expenditure | -853.29K - | -542.74K 36.39% | -96.61K 82.20% | |||||||||
free cash flow | -27.28K - | -52.66K 93.08% | -229.15K 335.12% | -495.06K 116.04% | -488.06K 1.41% | -5.83M 1,094.70% | -8.42M 44.46% | -7.26M 13.79% | -11.20M 54.28% | -1.50M 86.58% | -2.47M 64.44% |
All numbers in USD (except ratios and percentages)